| Thirty-day readmission among patients with alcoholic acute pancreatitis PP Argueta, M Salazar, I Vohra, JE Corral, FJ Lukens, JJ Vargo, P Chahal, ... Digestive Diseases and Sciences, 1-10, 2021 | 21 | 2021 |
| Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer: A retrospective cohort study I Achebe, C Mbachi, P Palacios, Y Wang, J Asotibe, A Ofori-Kuragu, ... Thrombosis research 199, 14-18, 2021 | 10 | 2021 |
| Thirty-day readmission after bariatric surgery: causes, effects on outcomes, and predictors PP Argueta, M Salazar, JJ Vargo, P Chahal, JJ Rodriguez, ... Digestive Diseases and Sciences 67 (3), 834-843, 2022 | 8 | 2022 |
| Incidence, burden, and predictors of readmission for acute alcoholic pancreatitis: a national analysis over 11 months LM Nieto, M Salazar, J Kinnucan, FJ Lukens, PP Argueta Digestive Diseases and Sciences 68 (2), 423-433, 2023 | 7 | 2023 |
| Evaluation of ferritin and transferrin ratio as a prognostic marker for hepatocellular carcinoma I Vohra, B Attar, V Katiyar, P Palacios, T Randhawa, MA Baig, E Flores, ... Journal of Gastrointestinal Cancer 52, 201-206, 2021 | 7 | 2021 |
| 90-Day Specific Readmission for Clostridium difficile Infection After Hospitalization With an Inflammatory Bowel Disease Flare: Outcomes and Risk Factors P Palacios Argueta, M Salazar, B Attar, R Simons-Linares, B Shen Inflammatory Bowel Diseases 27 (4), 530-537, 2021 | 5 | 2021 |
| B-type natriuretic peptide (BNP) predicts 90-day mortality and need for paracentesis in cirrhotic patients without systolic heart failure T Araujo, I Vohra, P Palacios, V Katiyar, E Flores, T Randhawa, Y Wang, ... Scientific Reports 11 (1), 1-7, 2021 | 5 | 2021 |
| Walking hyponatremia syndrome of inappropriate antidiuretic hormone secretion secondary to carbamazepine use: A case report PJ Palacios Argueta, GF Sánchez Rosenberg, A Pineda Journal of Medical Case Reports 12, 1-4, 2018 | 5 | 2018 |
| Drug-Induced Liver Injury Caused by “Khat,” an Herbal Stimulant PP Argueta, B Attar, C Sikavi, V Alagiozian-Angelova, S Mishra ACG case reports journal 7 (11), e00480, 2020 | 4 | 2020 |
| Outcomes and trends of endoscopic bariatric therapies (Ebt) among minority populations A Ouni, A Spaulding, AA Khosla, V Gomez, MA Edwards Obesity Surgery 33 (2), 513-522, 2023 | 3 | 2023 |
| Incidence, burden, and predictors of 11-month readmission in patients undergoing bariatric surgery DH Kim, FJ Lukens, D Ko, M Salazar, PT Kröner, EF Elli, V Kumbhari, ... Obesity Surgery 33 (1), 94-104, 2023 | 2 | 2023 |
| Severe pernicious anemia predisposing to hypoxic hepatitis C Mbachi, PP Argueta, Y Wang, B Mba ACG Case Reports Journal 6 (4), e00046, 2019 | 2 | 2019 |
| Sa1444 Safety of endoscopic ultrasound for pancreatobiliary lesions in patients with cirrhosis PP Argueta, M Salazar, A Bhatt, T Stevens, S Jang, JJ Vargo, ... Gastrointestinal Endoscopy 91 (6), AB193-AB194, 2020 | 1 | 2020 |
| Predictors and trends in hospitalized patients with inflammatory bowel disease and colorectal cancer that develop venous thromboembolism: a retrospective review P Palacios, BM Attar, C Mbachi, E Chukwujindu, I Paintsil, C Nwaichi, ... AMERICAN JOURNAL OF GASTROENTEROLOGY 114, S446-S447, 2019 | 1 | 2019 |
| 1460 An Unusual Histopathology of Colonic Polyps I Vohra, A Almoghrabi, V Katiyar, T Randhawa, P Palacios, V Kotwal, ... Official journal of the American College of Gastroenterology| ACG 114, S809-S810, 2019 | 1 | 2019 |
| Thirty‑Day Readmission Rates and Outcomes after hospitalization for Ischemic Colitis. A National Analysis SI Narvaez, JP Martinez, J Kinnucan, S Keilin, KJ Vega, PP Argueta, ... | | 2024 |
| GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS USE IS NOT ASSOCIATED WITH WORSE OUTCOMES OR INCREASED MORTALITY POST ENDOSCOPY: A MULTI-CENTER ANALYSIS PP Argueta, D Mejia, L Nieto, S Narvaez, P Kröner, F Lukens Gastrointestinal Endoscopy 99 (6), AB232, 2024 | | 2024 |
| 522 GLUCAGON LIKE PEPTIDE-1 RECEPTOR AGONISTS USE IS ASSOCIATED WITH LOWER MORTALITY AND IMPROVEMENT OF CARDIOVASCULAR OUTCOMES IN PATIENTS WITH MAFLD AND OBESITY: A MULTI … LM Nieto, D Mejia, S Narvaez, PP Argueta, KJ Vega, L Davisson, ... Gastroenterology 166 (5), S-1550-S-1551, 2024 | | 2024 |
| 850 PATIENTS WITH MAFLD TAKING GLUCAGON LIKE PEPTIDE-1 RECEPTOR AGONISTS DO NOT HAVE HIGHER INCIDENCE FOR HEPATOBILIARY CANCER BUT HAVE LOWER OVERALL MORTALITY: A MULTI-CENTER … LM Nieto, S Narvaez, PP Argueta, J Martinez, L Davisson, KJ Vega Gastroenterology 166 (5), S-1559, 2024 | | 2024 |
| Tu1944 GLUCAGON LIKE PEPTIDE-1 RECEPTOR AGONIST USE IS ASSOCIATED WITH LOWER INCIDENCE OF HEPATOBILIARY OR PANCREATIC CANCER IN PATIENTS WITH TYPE 2 DIABETES: A MULTI-CENTER … LM Nieto, S Narvaez, PP Argueta, J Martinez, KJ Vega, L Davisson Gastroenterology 166 (5), S-1472-S-1473, 2024 | | 2024 |
